Pfizer nears Metsera takeover

Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo

NEW YORK: Pfizer is closing in on a potential US$7.3bil takeover of weight-loss drug developer Metsera, the Financial Times has reported, citing unidentified sources.

The US pharma firm will acquire New York City-based Metsera for US$47.50 per share in cash, with an additional US$22.50 per share contingent on the achievement of certain performance milestones, the newspaper said